Showing 7711-7720 of 8649 results for "".
- Bausch + Lomb Introduces SimplifEYE IOL Delivery System for Envista Toric and Monofocal Preloaded IOLshttps://modernod.com/news/bausch-lomb-introduces-simplifeye-iol-delivery-system-for-envista-toric-and-monofocal-preloaded-iols/2478461/Bausch + Lomb announced the introduction of the SimplifEYE IOL delivery system, which is available exclusively for the enVista MX60PL and the enVista toric MX60PT, the first preloaded toric IOL available in the United States. “Surgeons recognize that using a preloaded IOL system can stream
- Volunteers to be Infected With Coronavirus in World’s First ‘Human Challenge’ Trialshttps://modernod.com/news/volunteers-to-be-infected-with-coronavirus-in-worlds-first-human-challenge-trials/2478437/Volunteers in London are to be infected with coronavirus early next year, in the world’s first COVID-19 “human challenge trials,” according to a Financial Times report. The project, first disclosed in the Financial Time
- FundamentalVR Expands Into Ophthalmologyhttps://modernod.com/news/fundamentalvr-expands-into-ophthalmology/2478436/FundamentalVR, a provider of VR surgical skills training and skills data analytics, announced the expansion of its surgical specialty capabilities with the addition of ophthalmology. Powered by the company’s patented HapticVR technology architecture that mimics the physical cues of surgical actio
- Low Vision Resources and Rehabilitation for Retinal Degeneration Patients: A Webinar to Discuss Critical Needs and Opportunitieshttps://modernod.com/news/low-vision-resources-and-rehabilitation-for-retinal-degeneration-patients-a-webinar-to-discuss-critical-needs-and-opportunities/2478431/The Foundation Fighting Blindness is hosting a low vision webinar to inform eye care professionals about the many opportunities to greatly enhance the quality of life, and provide hope, for their retinal disease patients. The interactive webinar is appropriate for all eye care professional
- Innovations Will Propel OCT Market to $549 Million in Revenue in 2020https://modernod.com/news/innovations-will-propel-oct-market-to-549-million-in-revenue-in-202/2478426/Recent innovations in optical coherence tomography (OCT) technology—such as systems that are combined with fundus imagers—and software advancements, including OCT angiography, are growing in popularity. At the same time promising new technologies on the horizon, such as at-home OCT devices, are g
- Concerns Over Surgical Waste Are Clouding Future of Single-Use Device Markethttps://modernod.com/news/concerns-over-surgical-waste-are-clouding-future-of-single-use-device-market/2478423/The global single-use surgical device market has shown steady growth over several decades, reaching a peak of $3.4 billion in 2019, but growing concerns over the amount of waste created by disposable surgical devices have raised questions about future growth prospects, according to a Market Scope
- Blue Light Glasses Improve Sleep and Work Productivity, IU Research Showshttps://modernod.com/news/blue-light-glasses-improve-sleep-and-work-productivity-iu-research-shows/2478421/During the pandemic, the amount of screen time for many people working and learning from home as well as binge-watching TV has sharply increased. New research finds that wearing blue light glasses
- New Orbis International Training Tool Prepares Ophthalmic Nurses for the Operating Roomhttps://modernod.com/news/new-orbis-international-training-tool-prepares-ophthalmic-nurses-for-the-operating-room/2478417/Orbis International announced the publication of the Orbis Ophthalmic Nursing Competency Assessment Rubric (ONCAR) for scrub nurses and technicians in Insight, the American Society of Ophthalmic Registered Nurses’ peer-reviewed clinical journal. The ONCAR is the first published tool
- New World Medical Registers New KDB GLIDE for Smooth, Precise Goniotomyhttps://modernod.com/news/new-world-medical-registers-new-kdb-glide-for-smooth-precise-goniotomy/2478414/New World Medical announced FDA registration of the KDB GLIDE as a Class 1 device, designed to give surgeons a refined, precise experience performing excisional goniotomy for treatment of glaucoma. The KDB GLIDE device improves on the successful Kahook Dual Blade technology by adding new features
- Tepezza Data From Phase 2 Clinical Trial Evaluate Longer-Term Responses in People Living with Thyroid Eye Disease (TED)https://modernod.com/news/tepezza-data-from-phase-2-clinical-trial-evaluate-longer-term-responses-in-people-living-with-thyroid-eye-disease-ted/2478415/Horizon Therapeutics announced new long-term follow-up data from the phase 2 clinical trial of Tepezza (teprotumumab-trbw), which showed a sustained response up to 1 year following completion of treatment for Thyroid Eye Disease (TED). These data will be presented as part of the